3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Biliary Tract Neoplasms
1
Interventions
Cyclophosphamide
5
Fluorouracil
4
pembrolizumab
3
fludarabine
3
Gemcitabine
3
Docetaxel
3
Cisplatin
3
belinostat
2
Quality of Life
2
Psychiatric Rehabilitation
2
Oxaliplatin
2
Observation
2
Leucovorin
2
Irinotecan
2
Filgrastim
2
Erlotinib Hydrochloride
2
Drug Therapy
2
Cetuximab
2
Carboplatin
2
Blood Specimen Collection
2
Bevacizumab
2
130-nm albumin-bound paclitaxel
2
umbralisib
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
toripalimab
1
seribantumab
1
rucaparib
1
resiquimod
1
poly ICLC
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
apixaban
×
Sarcoma
×
Clear all
NCT03139487
2020-01-06
PRIORITY
Asan Medical Center
Phase 2
Unknown
176 enrolled